About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
Individual will serve as a leader in Asset Optimization and will function as a Global Commercial Lead (GCL) to drive alignment across Global Commercial Development, International and US Commercial by enabling information flow to optimize asset opportunity. A key imperative will be to accelerate toxin pipeline strategy by expanding the neurotoxin platform into new therapeutic indications such that the asset value is maximized. As a Key strategic partner this individual will contribute to the global strategy and asset prioritization in close partnership with development teams and regional area leads.
* Lead analysis of respective market and asset opportunities; identifying key segment value drivers, growth opportunities, target product profiles, product positioning and revenue potential to maximize the asset; and representing the analysis at milestone executive governance meetings
* Drive development of early brand plans, including strategic positioning and early launch planning, by crystalizing commercial and strategic insights through analysis of product, brand, customer, consumer, and competitive information
* Support development of scientific platform and driving data generation to satisfy requirements for regional target product label and associated target product claims
* Lead internal processes that accurately reflect asset opportunity and providing the necessary analysis and support for business needs, e.g. Long Range Plan, Lifecycle Management
* Develop compelling presentations to convey diverse asset strategies to broad sets of stakeholder audiences, including senior executives via governance committees
* Lead the Brand Strategy Team and function as the Therapeutic Toxin commercial voice at Therapeutic Asset Strategy Council (TASC), and Asset Strategy Team (AST) meetings with Neurotoxin and organizational leadership
Qualifications
* Bachelors degree; Advanced degree (MBA, Ph.D. or M.D.) is preferred
* At least 10 years of relevant experience with a successful track record in pharmaceutical marketing - strong analytical and strategic marketing skills
* Previous experience in Commercial Development, Pipeline Management, In-line Marketing and/or Pharma Consulting roles, preferably within Neuroscience or Urology
* Experience in strategic positioning of products for success within competitive environments
* Scientific acumen & therapeutic understanding, with the ability to analyze complex datasets
* Strong financial acumen with a good understanding of P&L; drivers and the ability to develop appropriate investment & sales forecasts
* Deep understanding and experience of US &/or EU market access environments
* Experience with launch &/or on-market commercial teams
* Experience working within matrix-based teams and project management
* Works collaboratively and proactively, maintains high degree of planning, coordination & project management skills, demonstrated ability to problem solve & resolve conflict with diplomacy
* Builds strong relationships with peers and cross functional partners outside of immediate team
* Self-starter, learns fast, quickly grasps the essence of concepts, can change course rapidly where required, demonstrates intellectual curiosity
* Open to suggestion & experimentation for improvement, embraces ideas from others, encourages innovation but matches innovation to reality
* Demonstrates the ability to communicate ideas & make the complex easy for others to understand
* Executes highly effective working team meetings and is visibly inclusive and transparent in all he/she does
* Exhibits strong emotional intelligence, diplomacy, maintenance of confidentiality, maturity and organizational savvy
Leadership Skills
For this role, were looking for a leader who is:
* Excellence Focused
* Optimistic
* Open and Authentic
* Self-Starter
Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.